Therapeutic Drug Monitoring Market Size Forecast From 2026 To 2030: Key Industry Trends

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Therapeutic Drug Monitoring Market Forecast: What Value Will The Market Reach By 2030?

The therapeutic drug monitoring market has seen substantial expansion in recent years. Its valuation is anticipated to climb from $2.41 billion in 2025 to $2.67 billion in 2026, showing a compound annual growth rate (CAGR) of 10.9%. This past growth is largely due to the increasing utilization of narrow therapeutic index drugs, the expansion of hospital laboratory testing capabilities, the widespread adoption of immunoassay technologies, a rise in the occurrence of chronic diseases, and enhancements in analytical instrumentation.

The therapeutic drug monitoring market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $4.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This projected growth throughout the forecast period stems from factors such as the increasing need for precision medicine, the proliferation of automated diagnostic laboratories, a heightened emphasis on patient-specific dosing, progress in mass spectrometry technologies, and the rising uptake of real-time therapeutic monitoring. Significant trends during this period encompass the wider acceptance of LC-MS based monitoring methods, the increasing application of personalized medicine strategies, the broader integration of automated laboratory systems, an expansion in real-time drug level analysis, and a sharpened focus on precision dosing.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=44021670&type=smp&name=Therapeutic%20Drug%20Monitoring%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Therapeutic Drug Monitoring Market Growth Backed By Core Demand Fundamentals

The therapeutic drug monitoring market is projected to grow as drug consumption escalates. Drugs are substances administered for medical purposes to diagnose, treat, or prevent ailments in humans or animals. Therapeutic drug monitoring is utilized to refine drug dosage regimens by quantifying and adjusting drug concentrations within the bloodstream, thereby ensuring therapeutic effectiveness and minimizing adverse effects. For instance, in January 2024, the Office for Health Improvement & Disparities, a UK government department, reported that between April 2022 and March 2023, a total of 12,418 young people under 18 accessed alcohol and drug services, which signifies a 10% increase from the 11,326 cases observed in the preceding year. This escalating use of drugs is consequently propelling the therapeutic drug monitoring market.

Therapeutic Drug Monitoring Market Segment Trends And Revenue Contributors

The therapeutic drug monitoring market covered in this report is segmented –

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors

2) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Psychoactive Drugs, Other Drugs

3) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:

1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards

2) By Equipment: Analyzers, Incubators, Centrifuges

3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers

4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS)

Therapeutic Drug Monitoring Market Growth Trends Reshaping The Competitive Landscape

Leading companies in the therapeutic drug monitoring market are prioritizing the development of anti-idiotypic antibody technology to improve the sensitivity and specificity of assays used for precisely measuring biologic drug levels and evaluating patient immune responses. This anti-idiotypic antibody technology supports therapeutic drug monitoring by enabling exact detection and quantification of biologic drug levels, thereby ensuring accurate dosing and monitoring of patient immune reactions. For example, in June 2024, Bio-Rad Laboratories, a US-based biotechnology company, introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies designed for bioanalytical assays, which enhances pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These innovative antibodies increase the reliability of assays for antibody-drug conjugates (ADCs) and are essential for the therapeutic drug monitoring market, facilitating precise evaluations of drug concentrations and immune responses for optimal patient treatment.

Therapeutic Drug Monitoring Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the therapeutic drug monitoring market are Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

View The Full Therapeutic Drug Monitoring Market Report:

https://thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Therapeutic Drug Monitoring Market Regional Outlook: Where Is Opportunity Concentrated?

North America was the largest region in the therapeutic drug monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model